Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Breast Neoplasms 66Lymphoma 35Neutropenia 30Lymphoma, Large B-Cell, Diffuse 23Lymphoma, Non-Hodgkin 18Neoplasms 15Carcinoma, Non-Small-Cell Lung 14Ovarian Neoplasms 13Hodgkin Disease 13Sarcoma 11Multiple Myeloma 11Lymphoma, Mantle-Cell 10Lymphoma, Follicular 10Leukemia 10Burkitt Lymphoma 10Precursor Cell Lymphoblastic Leukemia-Lymphoma 9Lung Neoplasms 9Triple Negative Breast Neoplasms 8Rhabdomyosarcoma 7Leukemia, Lymphocytic, Chronic, B-Cell 7Chemotherapy-induced Neutropenia 7Central Nervous System Neoplasms 6Breast Neoplasms, Male 6Testicular Neoplasms 5Prostatic Neoplasms 5Neoplasm Metastasis 5Lymphoma, B-Cell, Marginal Zone 5Febrile Neutropenia 5Fallopian Tube Neoplasms 5Carcinoma, Ovarian Epithelial 5

Interventions

fludarabine phosphate 29Etoposide 26pegaspargase 24Peripheral Blood Stem Cell Transplantation 23Cyclophosphamide 23Whole-Body Irradiation 21Mycophenolic Acid 21Gemcitabine 19Busulfan 19Methotrexate 16Dexamethasone 16Tacrolimus 15Cyclosporine 14Antilymphocyte Serum 13Radiotherapy 12Oxaliplatin 10Rituximab 9Melphalan 8Asparaginase 8Doxorubicin 7Bortezomib 7spartalizumab 6Vorinostat 6Lenalidomide 6Flow Cytometry 6tislelizumab 5Vincristine 5Therapeutics 5Methylprednisolone 5Everolimus 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, Extranodal NK-T-Cell × pegfilgrastim × Clear all
NCT02392039 2019-04-23

Study of Loratadine for Pegfilgrastim Induced Bone Pain in Patients With Aggressive Lymphoma

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Terminated
1 enrolled
Lymphoid

Burkitt Lymphoma, Lymphoma, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell, Lymphoma, Extranodal NK-T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡